Contact Us |
| Please Fill out the form below |
| For those contacting us about link exhanges, please note we are in the process of upgrading the website and the link exchange will update with it. For now, we strongly recommend adding your link to Parking Noobie Link Swap in the meantime. Thank you for your patience! |
| Smokeless Tobacco Can Also Increase Cancer Risk |
| A review published in The Lancet Oncology finds that although users of smokeless tobacco products (STPs) likely have a lower cancer risk than smokers, they are still increasing their risk of developing several types of cancer. In the USA and Sweden, a finely cut or powered, flavored tobacco called moist snuff is the most popular form of STP used. In places like India, there is a wide range of products that are regularly consumed. |
| Link Between Low Level Cadmium Exposure And Lung Disease |
| New research suggests that cadmium is one of the critical ingredients causing emphysema, and even low-level exposure attained through second-hand smoke and other means may also increase the chance of developing lung disease. The University of Michigan School of Public Health study suggests that higher cadmium levels in the body as much as double the risk of developing a pulmonary disease diagnosis such as emphysema or chronic bronchitis. |
| Human Genome Sciences Completes Enrollment In Randomized Phase 2 Trial Of HGS-ETR1 In Non-Small Cell Lung Cancer |
| Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that it has completed the enrollment and initial dosing of patients in a randomized Phase 2 trial of HGS-ETR1 (mapatumumab) in combination with the chemotherapy agents paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC). |
| New Drug Delivery System Breaks The 'Mucus Barrier' |
| Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society. |
| Experimental Chemotherapy Regimen Shows Promise In Treating Advanced Lung Cancer |
| A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. |